[Disseminated lupus erythematosus: etiopathogenic factors].
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001402:B-Lymphocytes; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D006830:Hydralazine / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D008297:Male; D051379:Mice; D008814:Mice, Inbred NZB; D008815:Mice, Inbred Strains; D011342:Procainamide / Q000009:adverse effects; D013472:Sunlight; D013601:T-Lymphocytes; D014777:Virus Diseases / Q000150:complications
D000906:Antibodies; D001323:Autoantibodies; D006827:Hydantoins; D006830:Hydralazine; D011342:Procainamide; D007538:Isoniazid
Lupus érythémateux disséminé: facteurs étiopathogéniques